BAM
REGN icon

Byrne Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Byrne Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16.2K Hold
22
– – 0.01% 404
2026
Q2 		$13.7K Hold
22
– – 0.01% 398
2026
Q1 		$17K Sell
22
-1
-4% -$766 0.01% 357
2025
Q4 		$17.8K Buy
23
+1
+5% +$679 0.01% 362
2025
Q3 		$12.4K Sell
22
-5
-19% -$2.83K 0.01% 393
2025
Q2 		$14.2K Hold
27
– – 0.01% 369
2025
Q1 		$17.1K Buy
+27
New +$18.6K 0.01% 355
2024
Q4 		– Sell
-41
Closed -$34.4K – 262
2024
Q3 		$43.1K Hold
41
– – 0.03% 215
2024
Q2 		$43.1K Hold
41
– – 0.03% 217
2024
Q1 		$39.5K Hold
41
– – 0.03% 221
2023
Q4 		$35.8K Hold
41
– – 0.03% 221
2023
Q3 		$34K Hold
41
– – 0.03% 222
2023
Q2 		$29K Hold
41
– – 0.02% 287
2023
Q1 		$34K Hold
41
– – 0.02% 257
2022
Q4 		$29.6K Sell
41
-7
-15% -$5.17K 0.02% 280
2022
Q3 		$33K Hold
48
– – 0.03% 238
2022
Q2 		$28K Hold
48
– – 0.02% 238
2022
Q1 		$34K Sell
48
-6
-11% -$3.8K 0.02% 252
2021
Q4 		$34K Buy
+54
New +$33.2K 0.02% 244

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Byrne Asset Management's REGN Position: Q3 2026 in Review

Byrne Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2026 at 22 shares worth $16.2K. The position accounts for 0.01% of the portfolio, ranked #404.

Byrne Asset Management first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $43.1K in Q3 2024. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Byrne Asset Management held 22 shares of Regeneron Pharmaceuticals worth $16.2K as of Q3 2026.
  • Byrne Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Byrne Asset Management's portfolio in Q3 2026, its #404 holding.
  • Byrne Asset Management first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Byrne Asset Management's Regeneron Pharmaceuticals position peaked at $43.1K in Q3 2024.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.